Skip to main content
SpringerLink
Log in

Importance of G Protein-Coupled Receptor Genetics in Clinical Medicine

  • Protocol
  • First Online:
G Protein-Coupled Receptor Genetics

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

Abstract

Progress in areas of research from the field of G protein-coupled receptor (GPCR) signaling now shows that GPCRs are involved in a broad range of cellular regulatory activities. By virtue of widespread distribution and important roles in cell physiology and biochemistry, GPCRs play multiple important roles in clinical medicine. The understanding of how GPCRs interact with G proteins, effectors, as well as other regulatory proteins has enormous implications for clinical medicine. The rapid progress in determining three-dimensional structures of GPCRs, and more recently their regulators and effectors, has illuminated the search for mechanisms of activation and regulation and has allowed structure-based mutagenesis to test these ideas. The structural and mechanistic studies will in the future also provide opportunities to alter those interactions in pathological situations. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of genetics and neurobiology of mood will provide a broad perspective of this potential therapeutic target field. In this chapter, an attempt is made to show how far GPCR research advanced with regard to the genetics of clinical medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669–672

    Article  CAS  PubMed  Google Scholar 

  2. King N, Hittinger CT, Carroll SB (2003) Evolution of key cell signaling and adhesion protein families predates animal origins. Science 301:361–363

    Article  CAS  PubMed  Google Scholar 

  3. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996

    Article  CAS  PubMed  Google Scholar 

  4. Insel PA, Tang CM, Hahntow I et al (2007) Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim Biophys Acta 1768:994–1005

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Okada F, Tokumitsu Y, Ui M (1986) Desensitization of beta-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. J Neurochem 47:454–459

    Article  CAS  PubMed  Google Scholar 

  6. Rasmussen SG, Choi HJ, Rosenbaum DM et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383–387

    Article  CAS  PubMed  Google Scholar 

  7. Gilman AG (1987) G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56:615–649

    Article  CAS  PubMed  Google Scholar 

  8. Attwood TK, Findlay JB (1994) Fingerprinting G-protein-coupled receptors. Protein Eng 7:195–203

    Article  CAS  PubMed  Google Scholar 

  9. Foord SM, Bonner TI, Neubig RR et al (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279–288

    Article  CAS  PubMed  Google Scholar 

  10. Kolakowski LF (1994) GCRDb: a G-protein-coupled receptor database. Receptors Channels 2:1–7

    CAS  PubMed  Google Scholar 

  11. Drummond AH (1988) Lithium affects G-protein receptor coupling. Nature 331:388

    Article  CAS  PubMed  Google Scholar 

  12. Bjarnadottir TK, Gloriam DE, Hellstrand SH et al (2006) Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88:263–273

    Article  CAS  PubMed  Google Scholar 

  13. Vassilatis DK, Hohmann JG, Zeng H et al (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 100:4903–4908

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67:1414–1425

    Article  CAS  PubMed  Google Scholar 

  15. Tfelt-Hansen J, Ferreira A, Yano S et al (2005) Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells. Am J Physiol Endocrinol Metab 288:E1206–E1213

    Article  CAS  PubMed  Google Scholar 

  16. Schott M, Scherbaum WA, Morgenthaler NG (2005) Thyrotropin receptor autoantibodies in Graves’ disease. Trends Endocrinol Metab 16:243–248

    Article  CAS  PubMed  Google Scholar 

  17. Kierszenbaum F (2005) Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21:513–516

    Article  CAS  PubMed  Google Scholar 

  18. Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7–14

    Article  PubMed  Google Scholar 

  19. Wallukat G, Nissen E, Morwinski R et al (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 25:261–266

    Article  CAS  PubMed  Google Scholar 

  20. Joiner TE, Brown JS, Wingate LR (2005) The psychology and neurobiology of suicidal behavior. Annu Rev Psychol 56:287–314

    Article  PubMed  Google Scholar 

  21. Isometsa ET, Lonnqvist JK (1998) Suicide attempts preceding completed suicide. Br J Psychiatry 173:531–535

    Article  CAS  PubMed  Google Scholar 

  22. Robins E, Murphy GE, Wilkinson RH et al (1959) Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health Nations Health 49:888–899

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Cheng AT (1995) Mental illness and suicide. A case–control study in east Taiwan. Arch Gen Psychiatry 52:594–603

    Article  CAS  PubMed  Google Scholar 

  24. Rodriguez-Puertas R, Pascual J, Pazos A (1996) Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer’s disease brain tissues. Brain Res 728:65–71

    CAS  PubMed  Google Scholar 

  25. Balazs J, Lecrubier Y, Csiszer N et al (2003) Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. J Affect Disord 76:113–119

    Article  PubMed  Google Scholar 

  26. Henriksson MM, Aro HM, Marttunen MJ et al (1993) Mental disorders and comorbidity in suicide. Am J Psychiatry 150:935–940

    CAS  PubMed  Google Scholar 

  27. Ramakrishna D, Subhas MN (2010) Differential modulation of alpha-1 adrenoceptor subtypes by antidepressants in the rat brain. J Neural Transm 117:1423–1430

    Article  CAS  PubMed  Google Scholar 

  28. Bunney WE, Davis JM (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 13:483–494

    Article  CAS  PubMed  Google Scholar 

  29. Coppen A (1969) Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. Psychiatr Neurol Neurochir 72:173–180

    CAS  PubMed  Google Scholar 

  30. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522

    CAS  PubMed  Google Scholar 

  31. Devaki R, Shankar RS, Nadgir SM (2006) The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain. J Psychiatry Neurosci 31:246–252

    PubMed Central  PubMed  Google Scholar 

  32. Subhash MN, Nagaraja MR, Sharada S et al (2003) Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 43:603–609

    Article  CAS  PubMed  Google Scholar 

  33. Ramakrishna D, Subash MN, Sharada S et al (2004) Modulation of α1-adrenoceptors by tricyclic antidepressants in rat brain. J Neurochem 88:77

    Google Scholar 

  34. Narendra Sharath Chandra JN, Manish M, Sadashiva CT et al (2008) Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer’s dementia models. Neurochem Int 52:376–383

    Article  Google Scholar 

  35. Escriba PV, Ozaita A, Garcia-Sevilla JA (2004) Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 29:1512–1521

    Google Scholar 

  36. Gabilondo AM, Meana JJ, Garcia-Sevilla JA (1995) Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res 682:245–250

    Article  CAS  PubMed  Google Scholar 

  37. Hungund BL, Vinod KY, Kassir SA et al (2004) Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184–190

    Article  CAS  PubMed  Google Scholar 

  38. Wong ML, Licinio J (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3:136–151

    Article  CAS  PubMed  Google Scholar 

  39. Lesch KP, Aulakh CS, Tolliver TJ et al (1991) Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not clorgyline increase Go alpha subunits. Eur J Pharmacol 207:361–364

    Article  CAS  PubMed  Google Scholar 

  40. Lesch KP, Manji HK (1992) Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain. Biol Psychiatry 32:549–579

    Article  CAS  PubMed  Google Scholar 

  41. Delgado PL, Charney DS, Price LH et al (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411–418

    Article  CAS  PubMed  Google Scholar 

  42. Menkes DB, Rasenick MM, Wheeler MA et al (1983) Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219:65–67

    Article  CAS  PubMed  Google Scholar 

  43. Avissar S, Schreiber G, Danon A et al (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440–442

    Article  CAS  PubMed  Google Scholar 

  44. Colin SF, Chang HC, Mollner S (1991) Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Natl Acad Sci U S A 88:10634–10637

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Lesch KP, Aulakh CS, Tolliver TJ et al (1991) Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain. Eur J Pharmacol 207:355–359

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Author declares that there is no competing of interests. The author is grateful to Kamineni Institute of Medical Sciences for constant encouragement and support.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Kamineni Institute of Medical Sciences, Sreepuram, Nalgonda District, Andhra Pradesh, India

    Ramakrishna Devaki

Authors
  1. Ramakrishna Devaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oklahoma State University, Tulsa, Oklahoma, USA

    Craig W. Stevens

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Devaki, R. (2014). Importance of G Protein-Coupled Receptor Genetics in Clinical Medicine. In: Stevens, C. (eds) G Protein-Coupled Receptor Genetics. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-779-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-779-2_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-778-5

  • Online ISBN: 978-1-62703-779-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation